FTX-6058

· Fulcrum Therapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for FTX-6058, covering 2026-04-14 to 2026-04-14. Get the full timeline:

Most recent: Clinical Trial Update: Open-Label Extension Study to Pioneer Study 6058-SCD-101 [Phase 2]